Background: Chromosome regions 17q21 (BRCA1) and 10q23 (PTEN) have been found deleted in colorectal cancer.
Methods: We studied the frequency of loss of heterozygosity (LOH) in these 2 regions in 214 patients with only 1 sample per tumor and in 100 patients with several samples per tumor. Three microsatellite markers of each region were used for the LOH test. The polymerase chain reaction product was electrophoresed in 8% polyacrylamide gels, and band intensity was shown by silver staining.
Results: The proportions of LOH in the two regions were 38.4% for 17q21 and 30.8% for 10q23 in the group of 214 and were 47.7% for 17q21 and 34.7% for 10q23 in the group of 110434_2003_Article_876. We found a high correlation between the LOH in both regions (P < .001), where 81% of LOH in 10q23 region was matched by concomitant LOH in 17q21. In the group of tumors with several samples (group of 100), 39% and 68% did not present LOH in the 17q21 and 10q23 regions, respectively, in all of their tumor samples. However, in the 20 patients with LOH in both regions in the group of 100 (several samples per tumor), all samples with LOH in 10q23 also had LOH in 17q21, whereas not all samples with LOH in 17q21 had LOH in 10q23.
Conclusions: These results show that colorectal cancer is highly heterogeneous, at least for these tumors markers, and suggest a sequential acquisition pattern of these anomalies during tumor growth, in which changes in 17q21 could occur before those in 10q23.
Colorectal cancer LOH BRCA1PTENTumor heterogeneity
This is a preview of subscription content, log in to check access.
Diep CB, Thorstensen L, Meling GI, Skovlund E, Rognum TO, Lothe RA. Genetic tumor markers with prognostic impact in Dukes’ stages B and C colorectal cancer patients. J Clin Oncol 2003;21:820–9.CrossRefPubMedGoogle Scholar
Martinez-Lopez E, Abad A, Font A, et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998;114:1180–7.CrossRefPubMedGoogle Scholar
Solomon E, Voss R, Hall V, et al. Chromosome 5 allele loss in human colorectal carcinomas. Nature 1987;328:616–9.CrossRefPubMedGoogle Scholar
Ashton-Rickardt PG, Dunlop MG, Nakamura Y, et al. High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21–22. Oncogene 1989;4:1169–74.PubMedGoogle Scholar
Silva JM, Gonzalez R, Provencio M, et al. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res Treat 1999;53:9–17.CrossRefPubMedGoogle Scholar
Gao X, Zacharek A, Grignon DJ, Sakr W, Porter AT, Honn KV. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995;55:1002–5.PubMedGoogle Scholar
Mori T, Aoki T, Matsubara T, et al. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. Cancer Res 1994;54:1638–40.PubMedGoogle Scholar
García-Patiño E, Gomendio B, Lleonart M, et al. Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer. Cancer Genet Cytogenet 1998;104:119–23.CrossRefPubMedGoogle Scholar
Ali IU, Schriml LM, Dean M. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 1999;91:1922–32.CrossRefPubMedGoogle Scholar
Porter DE, Cohen BB, Wallace MR, et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutations in families linked to BRCA1 on chromosome 17q12–21. Br J Surg 1994;81:1512–5.CrossRefPubMedGoogle Scholar
Ford D, Easton D, Bishop D, Narod S, Goldgard D Breast Cancer Research Linkage Consortium. Risk of cancer in BRCA1-mutation carriers. Lancet 1994;343:692–5.CrossRefPubMedGoogle Scholar
Cropp CS, Nevanlinna HA, Pyrhonen S, et al. Evidence for involvement of BRCA1 in sporadic breast carcinoma. Cancer Res 1994;54:2548–51.PubMedGoogle Scholar
Wang ZJ, Taylor F, Churchman M, Norbury G, Tomlinson I. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol 1998;153:363–6.CrossRefPubMedPubMedCentralGoogle Scholar
Frayling IM, Bodmer WF, Tomlinson IP. Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. Cancer Genet Cytogenet 1997;97:64–9.CrossRefPubMedGoogle Scholar
Li DM, Sun HI. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997;57:2130–6.Google Scholar
Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356–62.CrossRefPubMedGoogle Scholar
Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943–7.CrossRefPubMedGoogle Scholar
Liaw D, Mash DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden’s disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64–7.CrossRefPubMedGoogle Scholar
Chi SG, Kim HJ, Park BJ, et al. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease. Gastroenterology 1998;115:1084–9.CrossRefPubMedGoogle Scholar
Guanti G, Resta N, Simone C, et al. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum Mol Genet 2000;9:283–7.CrossRefPubMedGoogle Scholar
Dicuonzo G, Angeletti S, Garcia-Foncillas J, et al. Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin Cancer Res 2001;12:4049–53.Google Scholar
Gayther SA, Warren W, Mazoyer S, et al. Germline mutations of the BRCA1 gene in breast cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995;11:428–33.CrossRefPubMedGoogle Scholar
Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1997;57:4420–6.PubMedGoogle Scholar
Vasen HF, Macklin JP, Meera-Khan P, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424–5.CrossRefPubMedPubMedCentralGoogle Scholar
Smith TM, Lee MK, Szabo CI, et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996;6:1029–49.CrossRefPubMedGoogle Scholar
García JM, Silva JM, Dominguez G, et al. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 1999;57:237–43.CrossRefPubMedGoogle Scholar
García JM, Silva JM, Dominguez G, Silva J, Bonilla F. Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations. Genes Chromosomes Cancer 2001;31:300–301.CrossRefPubMedGoogle Scholar